微小残留病
流式细胞术
医学
白血病
肿瘤科
内科学
免疫学
作者
Siqi Li,Lan‐Ping Xu,Yu Wang,Xiaohui Zhang,Huan Chen,Yu‐Hong Chen,Feng‐Rong Wang,Wei Han,Yuqian Sun,Chen-Hua Yan,Meng Lv,Feifei Tang,Xiao‐Dong Mo,Yanrong Liu,Kai‐Yan Liu,Ying‐Jun Chang,Xiao‐Jun Huang
出处
期刊:Blood
[Elsevier BV]
日期:2022-05-25
卷期号:140 (5): 516-520
被引量:65
标识
DOI:10.1182/blood.2021014604
摘要
Li et al delineate a novel technique for assessing measurable residual disease (MRD) by the assessment of isolated leukemia stem cells (LSCs). They report that assessment of MRD in LSCs provides a better prediction of outcome than standard multiparameter flow cytometry.
科研通智能强力驱动
Strongly Powered by AbleSci AI